Clinical Trials Directory

Trials / Completed

CompletedNCT04769011

Motor Impairments in Children With Autism Spectrum Disorder: a Multimodal Approach

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
106 (actual)
Sponsor
IRCCS Eugenio Medea · Academic / Other
Sex
All
Age
1 Year – 14 Years
Healthy volunteers
Accepted

Summary

The general goal of the present proposal, Progetto MOSAICO, is the identification of a multimodal panel of neuropsychological, kinematic, neurophysiological, and genetic markers associated with motor abnormalities present in ASD.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTClinical evaluationClinical evaluation of participants by means of Autism Diagnostic Observation Schedule, Social Responsiveness Scale, Children Behavior Check List, Conners' Scale
DIAGNOSTIC_TESTNeuropsychological evaluationThe participants' motor skills are measured using the Movement Assessment Battery for Children 2 (MABC2) (Henderson et al., 2007), the Developmental Coordination Disorder Questionnaire (DCDQ) (Wilson et al., 2007), and the kinematic analysis of a reach-to-drop task (Forti et al., 2011; Crippa et al., 2015).Sensorimotor domain will be also further investigated with NEPSY-II (Korkman et al., 2007) (Fingertip Tapping, Imitating Hand Positions, Manual Motor Sequences, and Visuomotor Precision).
DIAGNOSTIC_TESTNeurophysiological evaluationMagnetic Resonance Imaging (structural MRI and DTI)
DIAGNOSTIC_TESTGenetic evaluationEither blood or saliva will be obtained for participants for DNA collection. DNA will be extracted in the Molecular Biology Laboratory at the Scientific Institute IRCCS Medea. Captured exome libraries will be sequenced using the Illumina NextSeq 500 in 100 bp paired end reads. Postsequencing reads will be aligned using BWA Enrichment application on BaseSpace. VCF file will be then marked using wANNOVAR (Wang Genomics Lab). The analysis will be focused on non-synonymous variants enrichment in Gene Ontology and Human Phenotype.

Timeline

Start date
2018-01-02
Primary completion
2023-12-31
Completion
2023-12-31
First posted
2021-02-24
Last updated
2024-03-28

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT04769011. Inclusion in this directory is not an endorsement.